Task B1: Phase I Clinical Trial to Evaluate a Therapeutic for Carbapenem-resistant Enterbacterales (CRE) Infections

NIH RePORTER · NIH · N01 · $844,653 · view on reporter.nih.gov ↗

Abstract

The Early Phase Clinical Trial Units provide a vehicle for investigation of new agents in the treatment and prevention of infectious diseases and can carry out all aspects of interventional clinical trial implementation.

Key facts

NIH application ID: 11041972
Project number: 272201500005I-P00004-759302200057-1
Recipient: DYNPORT VACCINE COMPANY, LLC
Principal Investigator: GRAIG SHOCKEY
Activity code: N01
Funding institute: NIH
Fiscal year: 2024
Award amount: $844,653
Award type: —
Project period: 2021-12-14 → 2024-05-06